Ridgecrest Wealth Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Ridgecrest Wealth Partners's JNJ Position: Q2 2026 in Review
Ridgecrest Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 0.47% in Q2 2026, selling an estimated $6.53K and leaving 5,897 shares worth $1.5M. The position accounts for 0.72% of the portfolio, ranked #30.
Ridgecrest Wealth Partners first reported a position in JNJ in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.52M in Q1 2022. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Ridgecrest Wealth Partners held 5,897 shares of Johnson & Johnson worth $1.5M as of Q2 2026.
- Ridgecrest Wealth Partners sold 28 Johnson & Johnson shares in Q2 2026, an estimated $6.53K.
- Johnson & Johnson made up 0.72% of Ridgecrest Wealth Partners's portfolio in Q2 2026, its #30 holding.
- Ridgecrest Wealth Partners first reported a position in Johnson & Johnson in Q1 2021 and has held it in 22 quarters since.
- Ridgecrest Wealth Partners's Johnson & Johnson position peaked at $2.52M in Q1 2022.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Ridgecrest Wealth Partners's 13F filing for Q2 2026, filed 5 Aug 2026.